The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudy

Overview of attention for article published in Breast Cancer Research, March 2023

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 public wall post.

This is the first study worldwide, demonstrating that neoadjuvant add-on denosumab over a short-term period of 24 months does…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.